Fluorescent capabilities are the primary focus for laboratories with flow cytometer technologies
-
Upload
frost-sullivan -
Category
Healthcare
-
view
155 -
download
0
Transcript of Fluorescent capabilities are the primary focus for laboratories with flow cytometer technologies
Research PREVIEW for2015 Global Survey on Flow Cytometry Adoption Trends
Fluorescent Capabilities are the Primary Focus for Laboratories with Flow Cytometer
Technologies
Research Objectives
The primary goal of this research is to analyze the utilization of flow cytometry
instruments and reagents. Key information the survey seeks to collect include the
following:
• Factors that drive the selection of flow cytometers
• Predominantly used applications for flow cytometers
• Respondents’ most preferred brands and why
• How laboratories feel about test volumes in 2015
• Why laboratories are utilizing these specific products and how likely they are to
continue using these products
• Which of the clinical applications use flow cytometer predominantly
• Other complementary technologies used along with flow cytometry
• Unmeet needs and challenges
• Cells that are of interest
• Laboratory budgets for new equipment/reagent purchasesSource: Frost & Sullivan
Research Methodology
Methodology
Laboratories were invited to participate in an online survey in March 2015. To qualify for survey participation, respondents must work within a laboratory, hospital, academic facility, or government facility that use flow cytometry. Respondents should be a constant user of flow cytometer, belong to the scientific community, and be in a position to authorize purchases and handle laboratory budgets.
Sample
The target group was screened to ensure only qualified respondents participated. In total, 112 decision makers qualified for the survey, representing the following types of laboratories:
• Private laboratories include biotechnology firms, blood banks, independent laboratories, and private institutes.
• Government funded laboratories include government aided organizations and government affiliated research institutes.
• Academic refers to academic core flow facilities, imaging facilities, university labs, academic labs, and research group labs.
• Hospital laboratories refer to those flow facilities that are within hospitals, cancer centers, medical centers, and medical schools.
Source: Frost & Sullivan
Research Methodology (continued)
Organization Type Sample Size
Private labs 22
Academic core facility and research labs 43
Hospitals 21
Government funded labs 20
Pharma and contract research organizations (CRO) 6
Total 112
Source: Frost & Sullivan
Reporting Notes• The base (N) is significant (greater than 30) for all industries except pharma and CRO.• Respondents indicated a wide range of job titles such as lab directors, scientists, lab
managers, fish biologists, medical technologists, PhDs, postdoctoral, and technicians. For convenience, the different titles are grouped into 3 major categories in this study: directors and department heads, lab managers, and research professionals.
• In total, about 71 percent of respondents work in the United States, and about 13 percent work in Europe. Nevertheless, this study is considered global because the survey was open to respondents from all countries.
• Monetary values are reported in US dollars.• Due to rounding, percentages in charts and tables may not sum to 100.
Respondent Demographics
Base: All respondents (n=112)Q1: In which country are you located?Q2: Which of the following best describes your organization? Q3: What is your job title?
Respondent’s Country: Global, 2015
North America: 70.5%
Europe: 12.5%
Africa: 0.9%
South Asia: 9.8%
Rest of World (ROW): 6.3%
Organization Type: Global, 2015
Acedmic laboratory or core facility: 38.4%
Private laboratory: 19.6%
Hospital: 18.8%
Governement funded laboratory: 17.9%
Pharma and CRO: 5.4%
Director and department head: 25.0%
Lab manager: 35.7%
Research professional: 39.3%
Main Laboratory Role: Global, 2015
Source: Frost & Sullivan
Key Highlights
Source: Frost & Sullivan analysis.
Influencing Factors
A greater number of respondents showed a preference towards fluorescence capabilities, detection sensitivity, and intended application, whereas factors such as optical alignment, throughput capabilities, and data analysis seemed to take less precedence.
Capital BudgetCore facilities that cater to hospitals have the maximum budget to purchase new equipment. About 47.4 percent of the cases reported a budget of $71,000 to $1,000,000.
Complementary Technology
Polymerase chain reaction (PCR) and microarray are the technologies that are predominantly used with flow cytometry. Next-generation sequencing is rapidly catching up, which could lead to possible partnerships for automated workflows between flow instrument vendors and sequencing vendors.
Brand PerceptionBD Biosciences, Beckman Coulter (Danaher), and EMD Millipore remain strong as preferred brands, respectively. In addition, respondents have a strong preference for Sony Biotechnology as a future preferred brand.
BD Biosciences
Beckman Coulter
Miltenyi Biotec
EMD Millipore Corporation
0
1
2 3
4
5Low High
0
1
2 3
4
5Low High
0
1
2 3
4
5Low High
0
1
2 3
4
5Low High
Current Use Future Preference
Sony Biotechnology Inc.
0
1
2 3
4
5Low High
0
1
2 3
4
5Low High
0
1
2 3
4
5Low High
0
1
2 3
4
5Low High
0
1
2 3
4
5Low High 0
1
2 3
4
5Low High
Participants
Source: Frost & Sullivan
Brand Perception
Key Takeaway: BD Biosciences, Beckman Coulter (Danaher), and EMD Millipore remain strong; however, there is a strong preference for Sony Biotechnology as a future preferred brand.
The Full Analysis Features the Following Content
Section Slide Number
Research Background, Objectives, Methodology, and Respondent Demographics 5
Executive Summary 10
Utilization of Flow Cytometry 16
• Flow Cytometer Utilization 17
• Utilization by Research versus Clinical versus Industrial 18
• Overall Number of Colors Used 19
• Overall Number of Colors Used by Organization Type 20
Brand Perception 21
• Overall Brand Awareness of Flow Cytometry 22
• Brands Used by Organization Type 23
• Brands Used by Application Type 24
• Specific Brands Favored for Research Applications 25
• Specific Brands Favored for Clinical Applications 26
Laboratory Budgets and Future Adoption Plans 27
• Overall Laboratory Budget 28
9
The Full Analysis Features the Following Content (continued…)
Section Slide Number
• Laboratory Budget by Organization Type 29
• Future Adoption by Organization Type 30
• Future Preferred Brands by Organization Type 31
Complementary Technologies to Flow Cytometry 32
• Ancillary Technologies to Flow Cytometry 33
• Ancillary Technologies to Flow Cytometry by Organization Type 34
Test Volume Analysis 35
• Perception on Sample Inflow 36
• Sample Volume—Academic Core Labs and Research Institutes 37
• Sample Volume—Government Affiliated Centers 38
• Sample Volume—Private Labs 39
• Sample Volume—Hospital Labs 40
Research versus Clinical Use 41
• Predominantly Used Research Applications 42
• Predominantly Used Research Applications by Organization Type 44
• Predominantly Used Clinical Applications 46
Section Slide Number
• Predominantly Used Clinical Applications—Academic 48
• Predominantly Used Clinical Applications—Private 49
• Predominantly Used Clinical Applications—Government 50
• Predominantly Used Clinical Applications—Hospitals 51
Key Influencing Factors 52
Open Ended—Voice of the Customer 56
• Unmet Needs by Organization Type—Verbatim Responses 57
• Cells of Interest—Verbatim Responses 59
• Conclusions 62
Appendix 64
The Frost & Sullivan Story 66
Please contact Frost & Sullivan for upcoming research services on the global flow cytometry market.
The Full Analysis Features the Following Content (continued…)
Interested in Full Access? Connect With Us
Kayla Belcher Corporate Communications – North America
210.247.2450
Research Authors
Divyaa RavishankarSenior Industry
AnalystHealthcare
Greg CaressiVice President of
ResearchHealthcare
Facebookhttps://www.facebook.com/FrostandSullivan
LinkedIn Grouphttps://www.linkedin.com/company/frost-&-sullivan
SlideSharehttp://www.slideshare.net/FrostandSullivan
Twitterhttps://twitter.com/Frost_Sullivan
Frost & Sullivan Eventshttp://bit.ly/MvPRbQ
GIL Communityhttp://ww2.frost.com/gil-community/
Global Perspective40+ Offices Monitoring for Opportunities and Challenges
Industry ConvergenceComprehensive Industry Coverage Sparks Innovation Opportunities
Automotive&
Transportation
Aerospace & Defense Measurement &Instrumentation
Information &Communication Technologies
HealthcareEnvironment & BuildingTechnologies
Energy & PowerSystems
Chemicals, Materials& Food
Electronics &Security
Industrial Automation& Process Control
AutomotiveTransportation & Logistics
ConsumerTechnologies
Minerals & Mining